BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2010
View Archived Issues
INCB-7839 improves response to trastuzumab in metastatic HER2+ breast cancer
Read More
[131I]-Basiliximab is safe and induces responses in patients with refractory lymphoma
Read More
DanDrit's MelCancerVac cancer vaccine active in phase II trial in colorectal cancer
Read More
FDA grants emergency use authorization to Cepheid's Xpert Flu A Panel
Read More
Phase II investigation of diabetes treatment EGT-0001442 begins
Read More
EXC-001 enters phase II trials for improving surgery-related scar appearance
Read More
Novel inhibitors of IAP inhibitors claimed by the University of Michigan
Read More
IRM discovers novel ALK inhibitors for cancer therapy
Read More
Glaxo Wellcome discloses NK1 receptor antagonists for sleep disorders
Read More
Novel erythromycin derivatives for respiratory disorders in development at GSK
Read More
Pearl reports results from phase IIa trial of formoterol inhalation aerosol in COPD
Read More
Dendritic cells do not enhance activity of canarypox-HIV vaccine
Read More
Dh-404 reduces oxidative stress and may be beneficial to treat heart disease
Read More
UK scientists divulge novel B-Raf kinase inhibitors for cancer therapy
Read More
Keryx announces SPA agreement with FDA on phase III Zerenex trials in ESRD
Read More
Luitpold acquires PharmaForce
Read More
Novartis agreement to supply rhPDGF-BB to BioMimetic amended
Read More
Gilead's Quad regimen meets primary objective in phase II trial in HIV-infected adults
Read More
Takeda discloses novel SMO antagonists for cancer therapy
Read More
Novo Nordisk and Combine to collaborate in the field of autoimmune diseases
Read More
Phase II trial of AZX-100 for dermal scarring completes enrollment
Read More
FDA accepts development path for ARYx Therapeutics' anticoagulant tecarfarin
Read More
Encouraging top-line results reported from ACCORD COPD I study of aclidinium
Read More
BioMarin's amifampridine phosphate approved in the EU for LEMS
Read More
OncoMethylome and Roche to collaborate on phase III Avastin trial in glioblastoma
Read More
